Go to Member Homepage
Go to Submission Portal
Forgot your USERNAME OR PASSWORD?
Find us on the popular social networks
The Division for Drug Discovery and Development (DDD) serves to help its members teach, present and discuss the critical role of pharmacology in all phases of the drug discovery, development and registration process. The process encompasses, but is not limited to; target discovery and validation, medicinal chemistry, combinatorial chemistry, molecular modeling and drug design, structure-pharmacological function relationships, functional genomics and proteomics, high throughput screening, identification and development of natural products, nutraceuticals, pharmacokinetics and pharmacodynamics, clinical testing and drug regulation/registration, clinical contracting and pharmacoepidemiology and pharmacoeconomics.
The ASPET Annual Meeting site has all the details on division meetings and activities, including the business meeting for each division. Agendas are now available for download for the business meetings.
Dr. Timothy A. Esbenshade, Project Director/Sr. Principal Research Scientist, Global Research and Development, AbbVie has been elected chair-elect of the division. Dr. Tom J. Parry, Senior Director, Pharmacology and Safety, Research and Development, Acorda Therapeutics, Inc. has been elected secretary/treasurer-elect of the division.
The Division for Drug Discovery and Development congratulates the winners of the best abstract competition at EB 2015 for their outstanding posters.
The 2015 Division for Drug Discovery and Development Annual Meeting will take place on Monday, March 30 from 5:30 to 6:30 PM in Room 107C of the Boston Convention & Exhibition Center.
©The American Society for Pharmacology and Experimental Therapeutics (ASPET)9650 Rockville Pike, Bethesda, Maryland 20814-3995
ASPET.org is best viewed with Internet Explorer 7+, Firefox 3.5+ and Safari 3+.